E-LIB Suche - Ergebnisse für: Mauro, Michael J

1

Dose modification dynamics of ponatinib in patients with ch..:

Jabbour, Elias ; Apperley, Jane ; Cortes, Jorge...
Leukemia. 38 (2024) 3 - p. 475-481 , 2024

2

The Influence of Body Fat Dynamics on Pulmonary Immune Resp..:

Dhanyalayam, Dhanya ; Thangavel, Hariprasad ; Sidrat, Tabinda...
International Journal of Molecular Sciences. 25 (2024) 13 - p. 6823 , 2024

Link: https://doi.org/10.3390/..

3

Asciminib monotherapy in patients with chronic-phase chroni..:

Cortes, Jorge E. ; Sasaki, Koji ; Kim, Dong-Wook...
Leukemia. 38 (2024) 7 - p. 1522-1533 , 2024

Link: https://doi.org/10.1038/..

4

POSTER: CML-573 ASC2ESCALATE: A US, Phase II Open-Label, Si..:

Atallah, Ehab ; Mauro, Michael ; Sasaki, Koji...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S178 , 2023

Link: https://doi.org/10.1016/..

5

Eine klinische Perspektive auf die Behandlung von chronisch..:

García-Gutiérrez, Valentin ; Breccia, Massimo ; Jabbour, Elias..
Kompass Onkologie. 10 (2023) 1 - p. 2-15 , 2023

Link: https://doi.org/10.1159/..

6

Health-related quality of life of patients with resistant/i..:

Réa, Delphine ; Boquimpani, Carla ; Mauro, Michael J....
Leukemia. 37 (2023) 5 - p. 1060-1067 , 2023

Link: https://doi.org/10.1038/..

7

Health care resource utilization in 3L + patients with chro..:

Cortes, Jorge E. ; Rea, Delphine ; Mauro, Michael J....
Journal of Medical Economics. 26 (2023) 1 - p. 915-923 , 2023

Link: https://doi.org/10.1080/..

8

POSTER: CML-487 First-in-Human Phase I Study of ELVN-001, a..:

Mauro, Michael ; Lang, Fabian ; Kim, Dong-Wook...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S179 , 2023

Link: https://doi.org/10.1016/..

9

Treatment‐free remission after dasatinib in patients with c..:

Shah, Neil P. ; García‐Gutiérrez, Valentín ; Jiménez‐Velasco, Antonio...
British Journal of Haematology. 202 (2023) 5 - p. 942-952 , 2023

Link: https://doi.org/10.1111/..

10

CML-573 ASC2ESCALATE: A US, Phase II Open-Label, Single-Arm..:

Atallah, Ehab ; Mauro, Michael ; Sasaki, Koji...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S348-S349 , 2023

Link: https://doi.org/10.1016/..

11

POSTER: CML-398 Responses With Asciminib Continue to Deepen..:

Mauro, Michael ; Hochhaus, Andreas ; Hughes, Timothy...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S178 , 2023

Link: https://doi.org/10.1016/..

12

CML-398 Responses With Asciminib Continue to Deepen Over Ti..:

Mauro, Michael ; Hochhaus, Andreas ; Hughes, Timothy...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S340 , 2023

Link: https://doi.org/10.1016/..

13

CML-313 Post Hoc Analysis of Patient Responses by T315I Mut..:

Cortes, Jorge ; Deininger, Michael ; Lomaia, Elza...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S338 , 2023

Link: https://doi.org/10.1016/..

14

Asciminib vs bosutinib in chronic-phase chronic myeloid leu..:

Hochhaus, Andreas ; Réa, Delphine ; Boquimpani, Carla...
Leukemia. 37 (2023) 3 - p. 617-626 , 2023

Link: https://doi.org/10.1038/..

15

P665: RAPID AND DEEP RESPONSES WITH ASCIMINIB IN PATIENTS (..:

Hughes, Timothy ; Rea, Delphine ; Boquimpani, Carla...
HemaSphere. 7 (2023) S3 - p. e166161b , 2023

Link: https://doi.org/10.1097/..